Your Article Summary
Bayer to supply WHO with a product for the combination therapy of African sleeping sickness
BayNews International, 09/23/09
As part of the group's social engagement, Bayer is to make a further important contribution to the fight against tropical diseases. Over a period of five years, Bayer Schering Pharma will supply the World Health Organization with 400,000 tablets a year of its drug Lampit containing the active ingredient nifurtimox for use in eflornithine–nifurtimox combination therapy in the African countries affected.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


